Patents Assigned to Drugabilis
  • Adamantane or Bicyclic Monoterpenoid Derivatives for Use in the Treatment of Leishmaniasis
    Publication number: 20200281873
    Abstract: The present invention is in the field of therapeutic drugs to treat leishmaniasis. In particular, the invention concerns adamantane and bicyclic monoterpenoid derivatives for use in the treatment of leishmaniasis.
    Type: Application
    Filed: October 31, 2018
    Publication date: September 10, 2020
    Applicants: Commissariat a l'Energie Atomique et aux Energies Alternatives, Université Paris-Sud, Drugabilis
    Inventors: Daniel Gillet, Jean-Christophe Cintrat, Julien Barbier, Alain Pruvost, Philippe Loiseau, Joël Vacus